|
Approval to expand the indications for use to include closure of venous access sites in addition to the currently approved use for closure of arterial access sites. the device, as modified, will be marketed under the trade name mynxgrip vascular closure device and is indicated for use to seal femoral arterial and femoral venous access sites while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures utilizing a 5f, 6f or 7f procedural sheath.
|
